ISBN: 978-81-936678-8-0


PD1 – PDL1 Blockade Immunotherapy applied as a Lung Cancer Treatment: Main Results, Proven Impact and Recent Knowledge Extensions

Belloumi Nidhal*; Fenniche Soraya

The ability of lung cancer to evade immunosurveillance is ensured by an “immune deficiency state” leading to a tolerance towards tumoral cell’s antigens. Then, a theory that supports the anti-tumoral role of the immune system, made its strong proof, by individualization of a pathway to suppress this immune tolerance...


Molecular drug resistance mechanisms in Prostate Cancer

Sercan ERGÜN

Cancer cells are equipped for adjustment prompting drug resistance, which is the fundamental issue of treatment in all malignant growths, like Prostate Cancer (PC). Despite the fact that a wide scope of anticancer drugs, including research-based agents and medications confirmed for human use, is accessible, most of them lose their treatment efficiency in course of time...


Cytosponge: A breakthrough in detection of barrett’s esophagus

Swarupananda Mukherjee*; Saumyakanti Giri; Pamelika Das; Subhasis Maity

Barrett’s esophagus or BE is a very worst condition of GERD. It is the disease, which associated with gastroesophageal reflux. In this disease normal tissues of esophagus changes to tissues like intestine. This disease does not have any specific symptoms in early stage. But in fatal stage the symptoms may like to the symptoms related to GERD. As time increases this disease may produce the sever oesophageal adenocarcinoma...


Allium Species in the Fight Against Cancer

Isbilen O; Volkan E*

Cancer is one of the most common causes of death in the developed world affecting people from any age, race or gender. Breast cancer is the most common carcinoma observed in women followed by other forms of cancer like colorectal, lung, cervical and stomach cancers.


MedDocs Publishers

We always work towards offering the best to you. For any queries, please feel free to get in touch with us. Also you may post your valuable feedback after reading our journals, ebooks and after visiting our conferences.